Marc Balzarini

FDA investigator

Appears on 2 documents from 2017 to 2025, mostly at sites in Florida. Most often cites controls to prevent adulteration caused by facilities (21 CFR 106.20(a)).

2
Documents on file
6.5
Observations per 483
2017
First seen
2025
Most recent

What they cite most

From 13 observations
  • 21 CFR 106.20(a)
    Controls to prevent adulteration caused by facilities
    1
  • 21 CFR 106.40(f)(3)
    Controls to prevent adulteration caused by ingredients, containers, and closures
    1
  • 21 CFR 111.415
    What requirements apply to filling, assembling, packaging, labeling, and related operations?
    1
  • 21 CFR 111.560(a)(2)
    What requirements apply to the review and investigation of a product complaint?
    1
  • 21 CFR 111.75(b)(2)
    What must you do to determine whether specifications are met?
    1
  • 21 CFR 117.35(c)
    Sanitary operations
    1

Activity by year

2017: 1, 2025: 1

Where

Florida 1 · Iowa 1

Is Marc Balzarini coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

2 documents, newest first
FirmOpen
483 Blend.house Al lerton ,LLCFeb 20, 2025 · Allert on, Iowa
483 Pharmatech LLCMay 2, 2017 · Davie, Florida

About this profile

What does Marc Balzarini inspect?

Marc Balzarini appears on 2 documents on file covering 2 sites, mostly in Florida.

What do they cite most often?

21 CFR 106.20(a) (controls to prevent adulteration caused by facilities), followed by 21 CFR 106.40(f)(3) and 21 CFR 111.415.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Marc Balzarini is dated Feb 20, 2025.

FDA Investigator Marc Balzarini: 483s & Inspections · FDA Intel